
Johns Hopkins Medicine is heading a five‑year, $24 million NIH‑funded Hepatitis B and HIV Cure Consortium that brings together research teams from the United States, Brazil, India, Senegal and Uganda. The first year will enroll 450 participants co‑infected with HIV and chronic hepatitis B and 225 with hepatitis B alone, creating a multinational specimen repository. Seven specialized cores—virology, shared resources, multiomics, biostats, clinical, immunology and translational—will generate biomarkers, analyze viral‑host interactions and test cure strategies. The effort also includes training early‑stage investigators to sustain a global cure pipeline.
Johns Hopkins’ Artificial Intelligence and Technology Collaboratory for Aging Research (JH AITC) has distributed $20 million in National Institute on Aging funds to 45 states, D.C., Puerto Rico and the U.S. Virgin Islands, spawning 42 peer‑reviewed papers, seven market‑ready products and $11.7 million...

Johns Hopkins researchers, led by Adam Charles, secured a four‑year, $2.7 million NIH grant to build an AI‑enhanced optical imaging system that can record brain activity 20 to 50 times faster than current methods. The platform will translate voltage spikes and...